Select Medical Corporation Announces Pricing and Upsizing of its Offering of an Additional $675 million of its 6.250% Senior Notes due 2026

News provided by

Dec 05, 2019, 17:50 ET

MECHANICSBURG, Pa., Dec. 5, 2019 /PRNewswire/ -- Select Medical Holdings Corporation ("Holdings") (NYSE: SEM), today announced that Select Medical Corporation ("Select") has priced its private placement of $675 million aggregate principal amount of its 6.250% senior notes due 2026 (the "Additional Notes") as additional notes under the indenture pursuant to which it previously issued $550 million of 6.250% senior notes due 2026. The offering has been upsized from the previously announced amount of $625 million. The offering is expected to close on December 10, 2019, subject to the satisfaction of customary closing conditions.

Select intends to use a portion of the net proceeds of the offering, together with a portion of the proceeds from a proposed incremental term loan, and, if needed, available cash, to make an intercompany loan to Concentra, Inc. ("Concentra"), a joint venture subsidiary of Select, which will use the proceeds from such intercompany loan to repay in full all of Concentra's outstanding term loans, and to pay related fees and expenses.

The Additional Notes and related guarantees are being offered in a private placement, solely to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), or outside the United States to persons other than "U.S. persons" in compliance with Regulation S under the Securities Act. The Additional Notes and related guarantees have not been registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.

This notice does not constitute an offer to sell the notes, nor a solicitation for an offer to purchase the Additional Notes, in any jurisdiction in which such offer or solicitation would be unlawful. Any offer of the Additional Notes will be made only by means of a private offering memorandum. This press release is being issued pursuant to and in accordance with Rule 135c under the Securities Act.

Investor inquiries:
Joel T. Veit
Senior Vice President and Treasurer
717-972-1100
[email protected]

SOURCE Select Medical Corporation